Propanc Biopharma
$0.11
2
+$0+3.72% Tuesday 20:00
Statistics
Day High
0.11
Day Low
0.1
52W High
11
52W Low
0.1
Volume
339,740
Avg. Volume
2,006,685
Mkt Cap
0
P/E Ratio
0
Dividend Yield
-
Dividend
-
Earnings
14NovExpected
Expected EPS
N/A
Actual EPS
-0.0021
Financials
-Profit Margin
Unprofitable0Revenue
-2.01MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow PPCB. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of Jaén to commence the POP1 joint drug discovery program. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.
Show more...
CEO
Mr. James Nathanielsz
Employees
1
Country
US
ISIN
US74346N7012
Listings
0 Comments
Share your thoughts
FAQ
What is Propanc Biopharma stock price today?▼
The current price of PPCB is $0.11 USD — it has increased by +3.72% in the past 24 hours. Watch Propanc Biopharma stock price performance more closely on the chart.
What is Propanc Biopharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Propanc Biopharma stocks are traded under the ticker PPCB.
Is Propanc Biopharma stock price growing?▼
PPCB stock has fallen by -5.61% compared to the previous week, the month change is a -45.08% fall, over the last year Propanc Biopharma has showed a -98.07% decrease.
What were Propanc Biopharma earnings last quarter?▼
PPCB earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Propanc Biopharma revenue for the last year?▼
Propanc Biopharma revenue for the last year amounts to 0 USD.
What is Propanc Biopharma net income for the last year?▼
PPCB net income for the last year is -2.01M USD.
How many employees does Propanc Biopharma have?▼
As of April 01, 2026, the company has 1 employees.
In which sector is Propanc Biopharma located?▼
Propanc Biopharma operates in the Health Care sector.
When did Propanc Biopharma complete a stock split?▼
The last stock split for Propanc Biopharma was on January 29, 2025 with a ratio of 1:60000.
Where is Propanc Biopharma headquartered?▼
Propanc Biopharma is headquartered in Camberwell, US.